Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Radiotherapy & Radiosurgery
Radiotherapy for prostate cancer
What radiotherapy for prostate cancer involves, how external beam radiation, IMRT, SBRT and brachytherapy destroy tumour cells while sparing healthy tissue, what clinical evidence shows about cure rates, approximate treatment costs in Turkey compared with the UK, US and Germany, what daily sessions feel like, managing urinary and bowel side effects, long-term outcomes and how to choose an accredited radiation oncology centre.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Radiotherapy & Radiosurgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Radiotherapy for Prostate Cancer
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Radiotherapy for prostate cancer in Turkey: what it is and how it works
Radiotherapy for prostate cancer is a curative treatment using targeted ionizing radiation to destroy cancer cells in the prostate gland. When exploring what is radiotherapy for prostate cancer, patients learn that high-energy beams damage malignant DNA, halting cell division and triggering apoptosis, while modern targeting allows healthy adjacent tissues to recover. Hospitals in Turkey offer radiation therapy as primary curative treatment, as salvage therapy following surgery, or alongside hormone medications.
Radiation therapy offers long-term cancer control comparable to surgical removal (radical prostatectomy) for localised disease. This guide explains how treatment works, clinical evidence, approximate costs compared with the UK, US and Germany, recovery milestones, and how to verify cancer centres abroad. For wider oncology options, explore our guide to oncology treatments in Turkey.
How does radiation therapy target prostate tumours?
The prostate lies directly beneath the bladder and in front of the rectum. To eradicate cancer without injuring these organs, radiation oncologists use computerised planning and dynamic beam modulation. Techniques like Intensity-Modulated Radiotherapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) shape beams into hundreds of segments, matching the three-dimensional contours of the gland.
Advanced platforms, including helical tomotherapy, rotate continuous radiation around the pelvis while taking daily scans. Image-Guided Radiotherapy (IGRT) uses implanted gold fiducials or cone-beam computed tomography before every fraction to correct for internal organ motion, ensuring sub-millimetre delivery accuracy.
Does radiotherapy for prostate cancer work?
Yes. Landmark trials, including the ProtecT study and guidance from the European Association of Urology (EAU) and NICE, demonstrate that radiotherapy achieves durable long-term cancer control for localised disease. Ten-year cancer-specific survival rates for low- and intermediate-risk disease regularly exceed ninety percent, matching outcomes from radical prostatectomy.
Effectiveness depends on accurate risk staging. Radiation controls organ-confined tumours reliably, but cannot cure undetected distant metastases alone. In intermediate- and high-risk cases, international guidelines combine radiation with temporary androgen deprivation therapy (ADT) to weaken cancer cells. Cancer control is confirmed through gradual, steady decline in prostate-specific antigen (PSA) levels over one to two years rather than an immediate drop.
Radiotherapy for prostate cancer cost in Turkey compared with the UK, US and Germany
The figures below provide approximate cost ranges for complete curative radiotherapy courses across private healthcare systems. Final prices vary based on fractionation schedule, technology, imaging and package inclusions.
| Country | Approximate cost range |
|---|---|
| Turkey | €4,500 – €12,000 |
| United Kingdom | €12,000 – €28,000 |
| United States | €25,000 – €65,000 |
| Germany | €14,000 – €32,000 |
When comparing radiotherapy for prostate cancer price structures across hospitals, several clinical factors determine the quote. Cost drivers include the technique (five-session SBRT versus four- to seven-week IMRT), simulation scans (multiparametric MRI, PET-PSMA), fiducial markers and protective hydrogel rectal spacers. Choosing radiotherapy for prostate cancer Turkey packages allows international patients to bundle simulation, physics planning, all treatment fractions, consultations and local transfers into a single price. Request a written itemised quote before travelling.
External beam radiotherapy, brachytherapy or radical prostatectomy?
Men diagnosed with localised prostate cancer often evaluate external radiation alongside internal implants and surgical removal. Each modality suits distinct clinical indications.
| Treatment modality | Best suited to | Typical limits |
|---|---|---|
| External beam radiotherapy (IMRT / VMAT) | Localised and locally advanced disease across risk groups | Requires daily outpatient sessions over 4 to 8 weeks |
| Stereotactic body radiotherapy (SBRT / CyberKnife) | Low-risk and selected intermediate-risk localised tumours | Unsuitable for large glands or extensive pelvic nodal involvement |
| Brachytherapy (LDR or HDR) | Organ-confined disease with good baseline urinary flow | Requires anaesthesia and transperineal needle insertion |
| Radical prostatectomy | Localised tumours in surgically fit patients seeking organ removal | Invasive surgery carrying initial incontinence and recovery downtime |
While intracranial systems such as gamma knife treat cranial lesions, extracranial platforms and helical systems like tomotherapy target pelvic tumours. External radiotherapy avoids surgery and anaesthesia, preserving immediate urinary continence more reliably. Surgery provides immediate histological margin analysis. Discuss your anatomy, baseline urinary function and preferences with your multidisciplinary team.
Who is a suitable candidate for prostate radiation?
Good candidates include men with clinically localised prostate cancer (T1–T2), individuals with locally advanced disease (T3) treated alongside hormone therapy, and patients seeking to avoid major surgical risks. Radiotherapy is also widely used as salvage therapy if PSA levels rise after prostatectomy.
Patients with severe active inflammatory bowel disease (Crohn's disease or ulcerative colitis) face heightened risks of rectal injury and may be unsuitable. Severe pre-existing urinary obstruction or very large prostate glands (above 80–100 cm³) may require medical shrinking or surgical relief prior to radiation to avoid urinary retention. Prior pelvic radiation to overlapping fields usually precludes full-dose re-irradiation due to tissue tolerance limits.
What happens during prostate radiotherapy treatment step by step?
A curative radiotherapy course follows four organised stages from consultation through daily delivery:
- Consultation and staging: The radiation oncologist evaluates biopsy pathology, multiparametric MRI and PET-PSMA scans. Three gold fiducial seeds and a protective hydrogel spacer may be placed under local anaesthetic.
- Simulation: A custom pelvic vacuum cushion is moulded for immobilisation. A planning CT scan is acquired under strict bladder-filling and rectal-emptying protocols.
- Dosimetry planning: Medical physicists calculate complex beam trajectories, shaping the dose to the prostate while sparing the rectum, bladder and femoral heads.
- Daily treatment: You lie on the treatment couch while onboard imaging confirms marker alignment. The linear accelerator delivers the dose silently in ten to fifteen minutes without anaesthesia or sensation.
Radiotherapy for prostate cancer recovery and managing side effects
External beam therapy is performed as an outpatient procedure, meaning you remain mobile without surgical wound healing or bed rest. Patients can maintain light daily activities throughout their schedule.
Stay duration in Turkey depends on fractionation: five-session SBRT requires ten to fourteen days, whereas moderate hypofractionation (twenty fractions) requires four to five weeks. Radiotherapy for prostate cancer recovery milestones show that acute side effects peak towards the end of treatment and over the first two to four weeks post-therapy. Common acute effects include urinary frequency, mild dysuria, loose stools and fatigue.
Symptoms typically resolve within six to twelve weeks as tissues heal. Staying hydrated, avoiding dietary bladder irritants and performing gentle pelvic floor exercises aid recovery. Virtual check-ins after returning home allow your oncologist to track recovery milestones.
What are realistic results and PSA expectations?
Unlike cosmetic surgery, results from prostate cancer radiotherapy are evaluated through objective laboratory markers rather than visual changes. No surgical scars exist; success is measured by PSA monitoring.
Radiation eliminates cancer cells gradually over months, so PSA levels do not drop to zero immediately. Readings fall progressively over twelve to twenty-four months to a low baseline known as the PSA nadir. A low nadir (typically below 0.5–1.0 ng/mL) indicates durable tumour control. Around twelve to eighteen months post-treatment, some men experience a temporary, harmless "PSA bounce" that resolves spontaneously without indicating recurrence.
Long-term urinary continence remains preserved in the large majority of patients, with stress leakage being rare. Erectile function is generally maintained immediately after treatment, though gradual vascular changes may cause some decline over several years, which often responds to standard oral medication.
Risks and potential complications of prostate radiotherapy
Radiotherapy is carefully planned, but exposure to adjacent organs involves potential risks recognised by the NHS and oncology societies. When discussing radiotherapy for prostate cancer side effects, clinical teams categorise them into acute and late toxicities:
- Urinary effects: Acute radiation cystitis causes temporary frequency, urgency and burning. Late complications such as urethral stricture or minor haematuria occur in a small minority.
- Bowel and rectal effects: Transient radiation proctitis can produce rectal urgency or loose motions. Severe late rectal bleeding is rare, especially when protective hydrogel spacers are utilised.
- Sexual function: Gradual microvascular changes can reduce erectile rigidity over two to five years. Ejaculate volume typically diminishes or ceases over time.
- Secondary malignancy: Pelvic radiation carries a very small theoretical lifetime risk of secondary pelvic cancer, documented in professional registries at well below one percent.
How to choose an accredited cancer centre and questions to ask
Select cancer centres accredited by international bodies such as the Joint Commission International (JCI). Verify that your care is directed by a multidisciplinary tumour board including radiation oncologists, urologists and certified medical physicists operating modern linear accelerators equipped with cone-beam CT guidance.
Avoid facilities making absolute cure guarantees, clinics lacking daily image guidance, or providers unable to arrange structured post-treatment follow-up. Read how it works and request a detailed evaluation via our free quote page.
Key questions to ask your prospective clinic include:
- Which linear accelerator model and image-guidance software will be used for my treatment?
- Does your protocol incorporate implanted fiducials and hydrogel rectal spacers?
- How many fractions does my plan require, and what is my total recommended stay in Turkey?
- Will a full multidisciplinary tumour board review my diagnostic scans and plan?
- How will my PSA levels and recovery be monitored after I return home?
Hospitals with Oncology in Turkey
Frequently asked questions
Radiotherapy for prostate cancer uses focused, high-energy radiation beams or radioactive implants to destroy malignant cells in the prostate gland. The ionizing energy disrupts the DNA of cancer cells, preventing them from dividing while allowing adjacent healthy rectal and bladder tissues to recover. It is used as a primary curative treatment or following surgery to eliminate residual cells.
Yes, extensive clinical studies demonstrate that modern radiotherapy achieves long-term cancer control rates comparable to radical surgery for localised prostate cancer. Ten-year disease-free survival rates frequently exceed eighty-five percent for low- and intermediate-risk disease. For higher-risk tumours, radiation is often combined with temporary hormone therapy to maximize therapeutic effectiveness and prevent distant recurrence.
Radiotherapy for prostate cancer in Turkey typically costs between €4,500 and €12,000, compared with €12,000 to €28,000 in the UK and higher in the US. The price varies depending on whether treatment involves five-fraction stereotactic radiotherapy, multi-week intensity-modulated radiotherapy or brachytherapy. Written quotes usually include planning scans, medical physics, daily sessions and local transfers.
Because treatment is internal, before-and-after progress is measured through blood tests and imaging rather than photographs. A successful outcome shows prostate-specific antigen levels steadily decreasing to a low nadir over twelve to twenty-four months. Follow-up magnetic resonance imaging or PET scans confirm tumour regression, while urinary function stabilises following the initial post-treatment recovery period.
Most patients maintain normal daily routines during external beam treatment. Temporary side effects such as urinary frequency, mild bowel urgency and fatigue typically peak two to four weeks after therapy finishes and subside within six to twelve weeks. Full tissue healing and stabilization of urinary and erectile function continue over the subsequent twelve to eighteen months.
External beam radiation delivers imperceptible beams, so you feel no physical sensation while the linear accelerator rotates around you. Minor discomfort can arise later during the treatment course as surrounding tissues become temporarily inflamed, leading to mild burning during urination, urinary urgency or slight rectal sensitivity, which can be managed with standard medication.
Radiotherapy provides long-term, durable cancer control. Decades of oncology registries show that when cancer cells are successfully eradicated, curative outcomes remain stable over ten to fifteen years and beyond. Regular monitoring of prostate-specific antigen levels continues annually to confirm sustained remission and detect any potential biochemical changes as early as possible.
Modern radiotherapy is highly refined and safe. Image-guided delivery, intensity modulation and rectal spacer gels focus radiation tightly onto the prostate, sparing nearby organs. While temporary bowel, bladder and sexual side effects can occur, severe late complications develop in fewer than five percent of patients when treated at accredited centres by experienced radiation oncologists.
Clinical trials like the ProtecT study show equivalent long-term cancer survival between radiotherapy and surgical prostatectomy. Radiotherapy avoids surgical risks, hospital admission and immediate post-operative urinary leakage. However, it requires daily visits over one to several weeks and carries potential bowel sensitivity and gradual sexual changes. The right choice depends on individual anatomy, age and personal priorities.
Stay duration depends on the treatment technique. For stereotactic body radiotherapy delivering five fractions, an international stay of ten to fourteen days is standard. For conventional intensity-modulated radiotherapy spanning twenty to twenty-eight daily fractions, patients typically remain in Turkey for four to six weeks. A written schedule is established following initial simulation imaging.
Patient stories